Picato

Product NDC: 50222-503
11-digit product format: 502220503
Labeler code: 50222
Product ID: 50222-503_250a62f1-8f42-4306-884b-78c6f906988b
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: ingenol mebutate
Dosage form: GEL
Route: TOPICAL
Labeler: LEO Pharma Inc.
Application: NDA202833
Marketing category: NDA
Marketing start: 2012-01-23
Marketing end: 2022-04-30
Substance: INGENOL MEBUTATE
Active strength: 500 ug/g
Pharmacologic classes: Cell Death Inducer [EPC],Increased Cellular Death [PE]
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	50222-503		D	Discontinued by firm	2026-10-05
excluded package	package	50222-503	50222-503-47	D	Discontinued by firm	2026-10-05
excluded package	package	50222-503	50222-503-92	D	Discontinued by firm	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50222-503-92	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50222-503-47	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50222-503-92	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50222-503-47	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50222-503-92	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50222-503-47	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50222-503-92	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50222-503-47	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50222-503-92	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50222-503-47	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50222-503-92	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50222-503-47	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50222-503-92	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50222-503-47	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50222-503-92	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50222-503-47	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50222-503-92	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50222-503-47	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50222-503-92	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50222-503-47	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50222-503-92	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50222-503-47	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50222-503-92	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50222-503-47	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N202833-001	PICATO	INGENOL MEBUTATE	0.015%	GEL / TOPICAL		RLD	2012-01-23
N202833-002	PICATO	INGENOL MEBUTATE	0.05%	GEL / TOPICAL		RLD	2012-01-23

Orange Book patents#

Current patent rows page 1 of 1 · 23 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N202833-001	8372827	2026-12-18		Drug product	2013-03-08
N202833-001	8372828	2026-12-18		Drug product	2013-03-08
N202833-001	8377919	2026-12-18		Drug product	2013-03-08
N202833-001	8536163	2026-12-18	U-1440		2013-10-15
N202833-001	8716271	2026-12-18	U-1440		2014-05-28
N202833-001	8735375	2026-12-18	U-1440		2014-06-26
N202833-001	9820959	2026-12-18	U-1440	Drug product	2017-11-22
N202833-001	9833428	2026-12-18		Drug product	2017-12-06
N202833-001	9833429	2026-12-18		Drug product	2017-12-06
N202833-001	9861603	2026-12-18	U-1440		2018-01-16
N202833-001	8278292	2027-07-06		Drug product	2012-10-23
N202833-001	9789078	2033-05-15	U-2138		2017-11-15
N202833-002	8372827	2026-12-18		Drug product
N202833-002	8372828	2026-12-18		Drug product
N202833-002	8377919	2026-12-18		Drug product
N202833-002	8536163	2026-12-18	U-1440		2013-10-15
N202833-002	8716271	2026-12-18	U-1440		2014-05-28
N202833-002	8735375	2026-12-18	U-1440		2014-06-26
N202833-002	9820959	2026-12-18	U-1440	Drug product	2017-11-22
N202833-002	9833428	2026-12-18		Drug product	2017-12-06
N202833-002	9833429	2026-12-18		Drug product	2017-12-06
N202833-002	9861603	2026-12-18	U-1440		2018-01-16
N202833-002	8278292	2027-07-06		Drug product

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	N202833-001	PICATO	0.015%	GEL / TOPICAL		RLD	2012-01-23	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	N202833-002	PICATO	0.05%	GEL / TOPICAL		RLD	2012-01-23	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	N202833-001	PICATO	0.015%	GEL / TOPICAL	AB	RLD, RS	2012-01-23	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N202833-002	PICATO	0.05%	GEL / TOPICAL	AB	RLD, RS	2012-01-23	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N202833-001	AB	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N202833-002	AB	1	`74a2ff9319b5…`
2019-12-14 00:12 UTC	2019-12	N202833-001	AB	1	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N202833-002	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N202833-001	AB	1	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N202833-002	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N202833-001	AB	1	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N202833-002	AB	1	`ea99ee380514…`

Observed Orange Book patent history#

Patent history page 1 of 26 · 1,001 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N202833-001	8372827	2026-12-18		Drug product	2013-03-08	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-001	8372828	2026-12-18		Drug product	2013-03-08	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-001	8377919	2026-12-18		Drug product	2013-03-08	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-001	8536163	2026-12-18	U-1440		2013-10-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-001	8716271	2026-12-18	U-1440		2014-05-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-001	8735375	2026-12-18	U-1440		2014-06-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-001	9820959	2026-12-18	U-1440	Drug product	2017-11-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-001	9833428	2026-12-18		Drug product	2017-12-06	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-001	9833429	2026-12-18		Drug product	2017-12-06	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-001	9861603	2026-12-18	U-1440		2018-01-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-001	8278292	2027-07-06		Drug product	2012-10-23	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-001	9789078	2033-05-15	U-2138		2017-11-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-002	8372827	2026-12-18		Drug product		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-002	8372828	2026-12-18		Drug product		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-002	8377919	2026-12-18		Drug product		`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-002	8536163	2026-12-18	U-1440		2013-10-15	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-002	8716271	2026-12-18	U-1440		2014-05-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-002	8735375	2026-12-18	U-1440		2014-06-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-002	9820959	2026-12-18	U-1440	Drug product	2017-11-22	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-002	9833428	2026-12-18		Drug product	2017-12-06	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-002	9833429	2026-12-18		Drug product	2017-12-06	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-002	9861603	2026-12-18	U-1440		2018-01-16	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N202833-002	8278292	2027-07-06		Drug product		`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N202833-001	8372827	2026-12-18		Drug product	2013-03-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-001	8372828	2026-12-18		Drug product	2013-03-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-001	8377919	2026-12-18		Drug product	2013-03-08	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-001	8536163	2026-12-18	U-1440		2013-10-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-001	8716271	2026-12-18	U-1440		2014-05-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-001	8735375	2026-12-18	U-1440		2014-06-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-001	9820959	2026-12-18	U-1440	Drug product	2017-11-22	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-001	9833428	2026-12-18		Drug product	2017-12-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-001	9833429	2026-12-18		Drug product	2017-12-06	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-001	9861603	2026-12-18	U-1440		2018-01-16	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-001	8278292	2027-07-06		Drug product	2012-10-23	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-001	9789078	2033-05-15	U-2138		2017-11-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-002	8372827	2026-12-18		Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-002	8372828	2026-12-18		Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-002	8377919	2026-12-18		Drug product		`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-002	8536163	2026-12-18	U-1440		2013-10-15	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N202833-002	8716271	2026-12-18	U-1440		2014-05-28	`caaa826d4ba7…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50222-503-47	EA - Each	50222-503	5f7b0245-77de-4c1c-966e-38f59b6d42af	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ingenol mebutate	ACTIVE INGREDIENT	7686S50JAH	PICATO (INGENOL MEBUTATE) GEL [LEO PHARMA INC.]	5
ingenol mebutate	ACTIVE MOIETY	7686S50JAH	PICATO (INGENOL MEBUTATE) GEL [LEO PHARMA INC.]	5
benzyl alcohol	INACTIVE INGREDIENT	LKG8494WBH	PICATO (INGENOL MEBUTATE) GEL [LEO PHARMA INC.]	5
citric acid monohydrate	INACTIVE INGREDIENT	2968PHW8QP	PICATO (INGENOL MEBUTATE) GEL [LEO PHARMA INC.]	5
HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)	INACTIVE INGREDIENT	S38J6RZN16	PICATO (INGENOL MEBUTATE) GEL [LEO PHARMA INC.]	5
isopropyl alcohol	INACTIVE INGREDIENT	ND2M416302	PICATO (INGENOL MEBUTATE) GEL [LEO PHARMA INC.]	5
SODIUM CITRATE	INACTIVE INGREDIENT	1Q73Q2JULR	PICATO (INGENOL MEBUTATE) GEL [LEO PHARMA INC.]	5
water	INACTIVE INGREDIENT	059QF0KO0R	PICATO (INGENOL MEBUTATE) GEL [LEO PHARMA INC.]	5

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
7686S50JAH	INGENOL MEBUTATE	75567-37-2	INGENOL MEBUTATE

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50222-503-47	50222050347	2 TUBE in 1 CARTON (50222-503-47) > .47 g in 1 TUBE	2 tube	2012-01-23	2022-04-30	No	No	Current
50222-503-92	50222050392	2 TUBE in 1 CARTON (50222-503-92) > .47 g in 1 TUBE	2 tube	2012-01-23	2022-04-30	No	No	Current